Ultralife Corporation - Common Stock (ULBI)

Record $130 million backlog signals strong order momentum across defense and commercial segments.

Ultralife (NASDAQ:ULBI) reported second-quarter 2026 revenue of $47.9 million, operating income of $3.4 million and diluted earnings per share of $0.15, as the company cited stronger gross margins, a record backlog and continued investment in product development across its battery and communications

Ultralife (ULBI) Q1 2026 Earnings Transcript

Ultralife (NASDAQ:ULBI) reported a first-quarter loss for fiscal 2026 as lower sales, production disruptions and higher one-time costs weighed on results, even as management pointed to a record backlog and new product activity as signs of future growth. President and CEO Mike Manna said the company

Global supply chains continue to navigate a tumultuous landscape in November 2025, grappling with a complex interplay of geopolitical tensions, economic volatility, and environmental challenges. These disruptions, far from being transient, are now widely expected to persist for at least the next one to two years, fundamentally reshaping operational strategies

Ultralife Corp (ULBI) stock plunges after Q3 2025 earnings and revenue fall significantly short of analyst expectations.

The US market is yet to commence its session on Thursday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.

Ultralife Corp (ULBI) Q2 2025 earnings miss estimates with $48.56M revenue & $0.07 EPS, triggering a 20% pre-market drop. Analysts eye future recovery.

The battery solutions firm reported an adjusted income of $0.01 per share, while analysts expected $0.15 in earnings.